# L-Arginine

> L-Arginine is the substrate from which nitric oxide is made, and the clearest case in the Institute's stack of a supplement whose oral form is the wrong form.

Canonical: https://wiki.soapbox.community/wiki/L-Arginine
Section: Substances and pharmacology
Last updated: 2026-10-27
Publisher: Library of Ashurbanipal (Van Kush Family Research Institute), https://wiki.soapbox.community

**L-Arginine** is the substrate from which **nitric oxide** is made, and the clearest case in the Institute's stack of a supplement whose **oral form is the wrong form**.

## What it does

Arginine is a semi-essential amino acid and the sole nitrogen donor for **nitric oxide synthase** (NOS), which converts it to **nitric oxide and citrulline**. Nitric oxide is the endothelium's vasodilator signal; declining endothelial NO output is one of the better-characterised features of vascular ageing. Arginine is also a precursor for creatine, urea, ornithine, polyamines and proline, which puts it upstream of collagen as well.

## The first-pass problem

Oral arginine is **extensively degraded before it reaches circulation**. Intestinal and hepatic **arginase** consumes much of a dose on the way through, so plasma arginine rises far less than the label implies and the effect is dose-limited by gastrointestinal upset before it is limited by anything useful.

**Citrulline raises plasma arginine more reliably than arginine does.** Citrulline escapes first-pass arginase entirely and is converted to arginine in the kidney. This is the same lesson as folate versus L-methylfolate and iron sulphate versus chelate: the molecule on the label is not the molecule that arrives. The Institute's 2021 post used an **arginine/citrulline blend** for this reason before the pharmacology was written up.

## The BH4 coupling — why it sits beside the folate

NOS is a **BH4-dependent** enzyme, and this is the point of taking arginine in this stack rather than on its own.

When BH4 is scarce relative to substrate, NOS **uncouples**: instead of producing nitric oxide it produces **superoxide**, becoming a source of the oxidative stress it is supposed to oppose. Supplying more arginine to an uncoupled enzyme does not produce more NO. It produces more radical.

So arginine and L-methylfolate are not two independent entries in a list. **The folate keeps the cofactor regenerated so that the substrate has somewhere to go.** This is The Amplification Framework in its plainest form — substrate, cofactor, and the protection of the cofactor — and it is why vitamin C and carnosine belong in the same stack.

**ADMA** (asymmetric dimethylarginine), an endogenous NOS inhibitor that accumulates in renal and cardiovascular disease, competes at the same site and is the reason arginine's clinical results are inconsistent across populations.

## Cautions

- **After myocardial infarction** — the **VINTAGE MI** trial found higher mortality in the arginine arm among post-infarct patients. This is the single most important warning on the molecule and it is not a theoretical one.
- **Herpes simplex** — arginine supports viral replication and **lysine** opposes it. People with frequent HSV recurrences often react badly to arginine loading.
- **Hypotension** — additive with antihypertensives, nitrates and PDE5 inhibitors.
- **Asthma** — arginine metabolism is altered in asthmatic airways; evidence is mixed and caution is reasonable.
- **Renal and hepatic impairment** — arginine is handled by both organs.
- Gastrointestinal upset and osmotic diarrhoea are the usual practical dose limit.

See also: The Amplification Framework · L-Methylfolate · Amino Acid Complexes · Chelated Minerals · Stack Substances